Meyer HA - Search Results

1

DNA vaccination: using the patient's immune system to overcome cancer.

Eschenburg G, Stermann A, Preissner R, Meyer HA, Lode HN. Eschenburg G, et al. Among authors: meyer ha. Clin Dev Immunol. 2010;2010:169484. doi: 10.1155/2010/169484. Epub 2010 Dec 16. Clin Dev Immunol. 2010. PMID: 21197271 Free PMC article. Review.

2

Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomograms.

Stephan C, Siemssen K, Cammann H, Friedersdorff F, Deger S, Schrader M, Miller K, Lein M, Jung K, Meyer HA. Stephan C, et al. Among authors: meyer ha. Clin Chem. 2011 Jul;57(7):995-1004. doi: 10.1373/clinchem.2010.151472. Epub 2011 May 24. Clin Chem. 2011. PMID: 21610217

3

Reduced serum selenoprotein P concentrations in German prostate cancer patients.

Meyer HA, Hollenbach B, Stephan C, Endermann T, Morgenthaler NG, Cammann H, Köhrle J, Jung K, Schomburg L. Meyer HA, et al. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2386-90. doi: 10.1158/1055-9965.EPI-09-0262. Epub 2009 Aug 18. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19690186

4

miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.

Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K. Ratert N, et al. Among authors: meyer ha. J Mol Diagn. 2013 Sep;15(5):695-705. doi: 10.1016/j.jmoldx.2013.05.008. Epub 2013 Aug 12. J Mol Diagn. 2013. PMID: 23945108 Free article.

5

Value of prostate specific antigen density and percent free prostate specific antigen for prostate cancer prognosis.

Busch J, Hamborg K, Meyer HA, Buckendahl J, Magheli A, Lein M, Jung K, Miller K, Stephan C. Busch J, et al. Among authors: meyer ha. J Urol. 2012 Dec;188(6):2165-70. doi: 10.1016/j.juro.2012.07.106. Epub 2012 Oct 18. J Urol. 2012. PMID: 23083861

6

Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.

Stephan C, Meyer HA, Paul EM, Kristiansen G, Loening SA, Lein M, Jung K. Stephan C, et al. Among authors: meyer ha. Anticancer Res. 2007 Jul-Aug;27(4A):1833-6. Anticancer Res. 2007. PMID: 17649780 Free article. Clinical Trial.

7

Reference miRNAs for miRNAome analysis of urothelial carcinomas.

Ratert N, Meyer HA, Jung M, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K. Ratert N, et al. Among authors: meyer ha. PLoS One. 2012;7(6):e39309. doi: 10.1371/journal.pone.0039309. Epub 2012 Jun 20. PLoS One. 2012. PMID: 22745731 Free PMC article.

8

Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.

Wotschofsky Z, Liep J, Meyer HA, Jung M, Wagner I, Disch AC, Schaser KD, Melcher I, Kilic E, Busch J, Weikert S, Miller K, Erbersdobler A, Mollenkopf HJ, Jung K. Wotschofsky Z, et al. Among authors: meyer ha. Int J Biol Sci. 2012;8(10):1363-74. doi: 10.7150/ijbs.5106. Epub 2012 Oct 28. Int J Biol Sci. 2012. PMID: 23139634 Free PMC article.

9

Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network.

Stephan C, Meyer HA, Cammann H, Nakamura T, Diamandis EP, Jung K. Stephan C, et al. Among authors: meyer ha. Biol Chem. 2006 Jun;387(6):801-5. doi: 10.1515/BC.2006.101. Biol Chem. 2006. PMID: 16800743

10

Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations.

Stephan C, Xu C, Finne P, Cammann H, Meyer HA, Lein M, Jung K, Stenman UH. Stephan C, et al. Among authors: meyer ha. Urology. 2007 Sep;70(3):596-601. doi: 10.1016/j.urology.2007.04.004. Epub 2007 Aug 3. Urology. 2007. PMID: 17688922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters